retatrutide dementia Can be used to treat or promote weight loss in an older adult with dementia and obesity? How GLP-1s Could Transform Alzheimer's

Tirzepatide (approved GIP/GLP-1 agonist) achieves 15-22% weight loss

It is not FDA-approved and is not available by prescription in Hollywood, Miami, West Palm Beach, or anywhere in Florida outside of approved clinical trials

Beneficiaries who lose coverage, many of whom are on fixed incomes, are facing a difficult choice they can continue with medication that may have greatly improved their health and overall quality of life, but only if they are willing to risk financial security

Unequivocally, we do not see the same effects in humans as we do in rodents, says Elizabeth Pearce, MD, an endocrinologist and thyroid specialist at Boston Medical Center

Retatrutide remains in clinical trials and is not available for general prescription use